Pathogenetic significance of proinflammatory cytokines and dyslipidemia in the development of cardiovascular complications in patients with hypothyroidism
Journal Title: Міжнародний ендокринологічний журнал - Year 2017, Vol 13, Issue 4
Abstract
Background. The manifestation of violations in the morphofunctional state of the cardiovascular system is on one of the first places in the symptomatology of hypothyroidism, which is associated with various direct and indirect effects of thyroid hormones on the heart and blood vessels. The urgency of the question about the prevalence and peculiarities of dyslipidemia in patients with different types of hypothyroidism is still open. The purpose of our work is to study the prevalence of subclinical inflammatory syndrome (by the levels of C-reactive protein and interleukin-6) and to investigate the relationship between dyslipidemia, proinflammatory factors and the state of blood vessels in patients with hypothyroidism. Materials and methods. 101 patients with hypothyroidism were examined. The content of interleukin-6, C-reactive protein was determined by the enzyme immunoassay using NSCRP, ELISA (USA), IL-6 ELISA (Diaclone, France) kits according to the manufacturer’s instructions. Results. It was found that levels of C-reactive protein were higher in patients with hypothyroidism than in euthyroid individuals. Also, the interleukin-6 content in patients with hypothyroidism was significantly higher (by 66.6 %) than in healthy individuals. According to the analysis of average values, the content of interleukin-6 in idiopathic hypothyroidism exceeded the level in health persons by 16.5 %. The content of total cholesterol in patients with hypothyroidism was 18.5 % higher than in apparently healthy individuals. Conclusions. The obtained data showed that persistence of proinflammatory states and dyslipidemia is one of the important factors of cardiovascular system lesion in patients with hypothyroidism. The proportion of people with aberrant levels of C-reactive protein, interleukin-6 and dyslipidemia is prevalent among patients with idiopathic hypothyroidism.
Authors and Affiliations
V. S. Vernygorodskyi, N. M. Fetisova, M. V. Vernygorodska
Keywords
Related Articles
- EP ID EP213062
- DOI 10.22141/2224-0721.13.4.2017.106653
- Views 71
- Downloads 0
Calcitonin, Osteocalcin and Osteopontin in Lung Cancer
Background. Lung cancer markers are low levels of the hormone calcitonin in the blood, and high levels of proteins osteocalcin and osteopontin, connected to each other, reflect the processes of bone metastasis and have a...
Endocrine Ophthalmopathy in Autoimmune Thyroid Diseases
The article presents modern data about risk factors, mechanisms of development, clinical features of endocrine ophthalmopathy, as well as information regarding current approaches to diagnosis, treatment and prevention of...
Comparative Analysis of Espa-Carb Efficacy in Patients with Hyperthyroidism
The article discusses approaches to conservative treatment in patients with diffuse toxic goiter (DTG). The purpose of research — evaluation of coverage, therapeutic efficacy and tolerability of carbimazole (Espa-Carb) c...
Individual Approach to the Treatment of Diabetes Mellitus Type 2: When, to Whom and What are the Alternative Options Besides Metformin
The article discusses the question of strategy choice for hypoglycemic treatment in patients with diabetes type 2 who have contraindications to metformin or its intolerance.
Efficacy of Metformin and Atorvastatin in Correction of Indices of Carbohydrate and Lipid Metabolism in Patients with Type 2 Diabetes Mellitus
This paper presents the results of metformin and atorvastatin use in patients with type 2 diabetes mellitus (DM). 25 patients with type 2 diabetes mellitus (DM) had been observed. Patients were treated with metformin and...